Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 2
1(20.0%)
5Total
N/A(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07524166Not ApplicableCompleted

Empowerment-Based Health Education and Type 2 Diabetes Mellitus

Role: lead

NCT07136636Recruiting

Speech of Kids After Neonatal Encephalopathy

Role: collaborator

NCT07098013Not ApplicableCompleted

Unguided Internet-based Relaxation Program for Anxiety

Role: lead

NCT02918864Phase 2Completed

Oxytocin and Social Cognitive Skills Groups

Role: collaborator

NCT05746234Not ApplicableUnknown

Emotion Regulation For All (ER4ALL) Study

Role: collaborator

NCT03840642Not ApplicableCompleted

Examining an Adaptive Telehealth Intervention

Role: collaborator

All 6 trials loaded